Search Results - "Hemmer, Patrick H. J."
-
1
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases
Published in JAMA oncology (01-08-2020)“…To date, there are no data on the value of adjuvant systemic chemotherapy following up-front resection of isolated synchronous colorectal peritoneal…”
Get more information
Journal Article -
2
Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer
Published in Annals of surgical oncology (01-12-2021)Get full text
Journal Article -
3
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial
Published in JAMA surgery (01-08-2021)“…To date, no randomized clinical trials have investigated perioperative systemic therapy relative to cytoreductive surgery and hyperthermic intraperitoneal…”
Get more information
Journal Article -
4
Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible
Published in Annals of surgical oncology (01-09-2021)“…Background There is no consensus yet for the best treatment regimen in patients with recurrent rectal cancer (RRC). This study aims to evaluate toxicity and…”
Get full text
Journal Article -
5
ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases—A Nationwide Population-Based Study
Published in Annals of surgical oncology (01-07-2024)Get full text
Journal Article -
6
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study
Published in Annals of surgical oncology (01-06-2024)“…Background Before 2016, patients with isolated synchronous colorectal peritoneal metastases (PMCRC) diagnosed in expert centers had a higher odds of undergoing…”
Get full text
Journal Article -
7
Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer
Published in Journal of Nuclear Medicine (01-05-2020)“…Negative circumferential resection margins (CRM) are the cornerstone for the curative treatment of locally advanced rectal cancer (LARC). However, in up to…”
Get full text
Journal Article -
8
Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery
Published in Annals of surgical oncology (01-04-2020)“…Objective The aim of this study was to evaluate the introduction of diagnostic laparoscopy (DLS) in patients with colorectal peritoneal metastases (PM) to…”
Get full text
Journal Article -
9
Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial
Published in BMC cancer (21-03-2019)“…Approximately 20-30% of patients with pT4 colon cancer develop metachronous peritoneal metastases (PM). Due to restricted accuracy of imaging modalities and…”
Get full text
Journal Article -
10
Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Published in Annals of surgical oncology (01-08-2020)“…Background The extent of surgery (ES) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is a well-known risk factor for…”
Get full text
Journal Article -
11
Fasciocutaneous Lotus Petal Flap for Perineal Wound Reconstruction after Extralevator Abdominoperineal Excision: Application for Reconstruction of the Pelvic Floor and Creation of a Neovagina
Published in Annals of surgical oncology (01-11-2016)“…Background The extralevator abdominoperineal excision (ELAPE) procedure creates an extensive soft tissue defect of the pelvic floor. It has been suggested that…”
Get full text
Journal Article -
12
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial
Published in BMC cancer (24-05-2015)“…The peritoneum is the second most common site of recurrence in colorectal cancer. Early detection of peritoneal carcinomatosis (PC) by imaging is difficult…”
Get full text
Journal Article -
13
Bioelectrical Impedance Analysis and Mid-Upper Arm Muscle Circumference Can Be Used to Detect Low Muscle Mass in Clinical Practice
Published in Nutrients (01-07-2021)“…Identification of low muscle mass becomes increasingly relevant due to its prognostic value in cancer patients. In clinical practice, mid-upper arm muscle…”
Get full text
Journal Article -
14
Molecular fluorescence‐guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review
Published in Journal of surgical oncology (01-08-2018)“…Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy…”
Get full text
Journal Article -
15
Incidence and predictors of postoperative delirium after cytoreduction surgery‐hyperthermic intraperitoneal chemotherapy
Published in Journal of surgical oncology (01-02-2018)“…Background Incidence of, and baseline characteristics associated with delirium in patients after cytoreduction surgery‐hyperthermic intraperitoneal…”
Get full text
Journal Article -
16
-
17
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Published in The lancet. Gastroenterology & hepatology (01-10-2019)“…Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon cancer are at risk of developing peritoneal metastases, often without…”
Get more information
Journal Article -
18
Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Published in Annals of surgical oncology (01-10-2020)“…Background Previous studies have shown that, overall, quality of life (QoL) decreases within the first 3–6 months after cytoreductive surgery with hyperthermic…”
Get full text
Journal Article -
19
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study
Published in BMC cancer (25-04-2019)“…Background Upfront cytoreductive surgery with HIPEC (CRS-HIPEC) is the standard treatment for isolated resectable colorectal peritoneal metastases (PM) in the…”
Get full text
Journal Article -
20
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
Published in Annals of surgical oncology (01-07-2019)“…Background Careful selection of patients with colorectal peritoneal metastases (PM) for cytoreductive surgery (CRS) with hyperthermic intraperitoneal…”
Get full text
Journal Article